Skip to main content
Home
Canada
Business
Investing
Life
Opinion
World
Politics
Personal Finance
Culture
More
More
Latest in
More
Real Estate
Sports
Drive
Watchlist
For You
Events
Find clarity in the chaos.
Subscribe now and save 70%
Flash Sale
Digital access
Digital + home delivery
TSX
-0.03%
S&P 500
0.8%
DOW
-0.16%
NASDAQ
1.63%
Oil
1.83%
Dollar
-0.06%
Gold
-0.97%
tsx movers:
CNQ-T
-2.44%
TRP-T
+1.63%
ENB-T
+1.32%
MFC-T
-0.09%
Instrument Name
Kenvue Inc
Instrument Symbol
(KVUE-N)
Instrument Exchange
NYSE
Add to Watchlist
Create Alerts
USD
Today's Change
Real-Time
Last Update
Last Sale
Cboe BZX Real-Time
USD
After Hours
Change
After Hours
Last Update
After Hours
Price
Volume
Summary
Charts
Dividends
Analysts
Price Report
Financials
Profile
Statistics
Insiders
Kenvue Inc
1 KENVUE WAY
SUMMIT NJ 07901 USA
P:
908-874-1200
http://www.kenvue.com
Sectors & Indices
Sector
Industry
Employees
SIC-2844 Perfumes, Cosmetics & Other Toilet Preparati
Consumer Prdts - Misc Staple
Indices S&P 500
Indices S&P 500 Consumer Staples
Indices Russell 1000
Indices Russell 3000
Indices S&P 500 Value
Profile
Kenvue Inc. is a pure-play consumer health company. Its brand portfolio includes AVEENO(R), BAND-AID(R) Brand Adhesive Bandages, JOHNSON'S(R), LISTERINE(R), NEUTROGENA(R), TYLENOL(R) and ZYRTEC(R). Kenvue Inc. is based in SKILLMAN, N.J.
Key Executives
Name
Title
Amit Banati
CFO
Kirk L. Perry
CEO/Director
Michael Wondrasch
Chief Technology Officer/Other Executive Officer
Luani Alvarado
Other Executive Officer
Carlton Lawson
President, Geographical
Matthew Orlando
General Counsel
Meredith Stevens
COO
Caroline Tillett
Chief Scientific Officer
Russell Dyer
Other Executive Officer
Anindya Dasgupta
President, Geographical
Jonathan Halvorson
Chief Marketing Officer/Other Executive Officer
Leonardo Curado
President, Geographical
Carlos De Jesus
President, Geographical
More from The Globe
Lululemon appoints long-time Nike executive Heidi O’Neill as new CEO
April 22, 2026
Bullish on Pembina Pipeline Corp.
Monica Rizk
April 21, 2026
trade secrets
How investors should digest the stock market’s ‘sugar high’
April 21, 2026
newsletter
Market Factors: Top picks, sector review for income-heavy utilities sector
April 20, 2026
The most oversold and overbought stocks on the TSX
April 20, 2026
The highest-yielding stocks on the TSX, plus risk data
April 20, 2026
top links
Barlow’s Research Roundup: These stocks are biggest winners from oil price volatility
April 20, 2026
It’s not just Allbirds - another meme-stock season is on the horizon, Vanda Research says
April 17, 2026